Literature DB >> 9024386

Differing proteinuria control with cyclosporin and tacrolimus.

K Budde, L Fritsche, H H Neumayer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9024386     DOI： 10.1016/S0140-6736(05)62830-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Tacrolimus Monotherapy after Intravenous Methylprednisolone in Adults with Minimal Change Nephrotic Syndrome.

Authors:  Xiayu Li; Zhangsuo Liu; Li Wang; Rong Wang; Guohua Ding; Wei Shi; Ping Fu; Yani He; Genyang Cheng; Shukun Wu; Bing Chen; Juan Du; Zhiming Ye; Ye Tao; Bengang Huo; Heng Li; Jianghua Chen
Journal:  J Am Soc Nephrol       Date:  2016-11-02       Impact factor: 10.121

2.  Tacrolimus therapy in pediatric patients with treatment-resistant nephrotic syndrome.

Authors:  Kim Loeffler; Manjula Gowrishankar; Verna Yiu
Journal:  Pediatr Nephrol       Date:  2004-02-03       Impact factor: 3.714

3.  Efficacy and Safety of Cyclosporine versus Tacrolimus in Steroid and Cyclophosphamide Resistant Nephrotic Syndrome: A Prospective Study.

Authors:  N Prasad; R Manjunath; D Rangaswamy; A Jaiswal; V Agarwal; D Bhadauria; A Kaul; R Sharma; A Gupta
Journal:  Indian J Nephrol       Date:  2018 Jan-Feb

4.  Clinicopathologic Features and Risk Factors of Proteinuria in Transplant Glomerulopathy.

Authors:  Qiang Zhang; Klemens Budde; Danilo Schmidt; Fabian Halleck; Michael Duerr; Marcel G Naik; Manuel Mayrdorfer; Wiebke Duettmann; Frederick Klauschen; Birgit Rudolph; Kaiyin Wu
Journal:  Front Med (Lausanne)       Date:  2021-07-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.